Lavipharm

Lavipharm Assets per Share

The Total Assets per Share of Lavipharm (LAVI.AT) as of Oct 16, 2026 is 0.77 EUR. In the previous year, Total Assets per Share was 0.74 EUR — a change of 3.78% (higher).

Assets per Share

0.77EUR

YoY

3.78%

Last updated:

Total Assets per Share of Lavipharm is 2025 0.77 EUR. Total Assets per Share of Lavipharm was 2024 0.74 EUR. It decreases by 3.78% higher compared to the previous year.

The Lavipharm Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
0.25 EUR
Jan 1, 2019
0.29 EUR
Jan 1, 2020
0.30 EUR
Jan 1, 2021
0.31 EUR
Jan 1, 2022
0.68 EUR
Jan 1, 2023
0.68 EUR
Jan 1, 2024
0.74 EUR
Jan 1, 2025
0.77 EUR
The Lavipharm Assets per Share history
YEARAssets per ShareYoY
0.77EUR+3.78%
0.74EUR+9.32%
0.68EUR+0.54%
0.68EUR+116.47%
0.31EUR+4.15%
0.30EUR+2.46%
0.29EUR+17.96%
0.25EUR-6.50%
0.27EUR-6.99%
0.29EUR-41.52%
0.49EUR+9.79%
0.44EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lavipharm Stock analysis

What does Lavipharm do? Lavipharm SA is a pharmaceutical company based in Athens, Greece, operating within the Health Care sector. The company, listed on the Vienna Stock Exchange under ticker LAVI.AT, has an ISIN code of GRS246003008. Lavipharm SA was founded through an IPO on November 8, 1995, and currently employs 184 full-time staff. The company engages in the manufacture and import of pharmaceuticals and veterinary products. Its product portfolio includes pharmaceuticals for anti-inflammatory, asthma, neurological, antiseptic, analgesic, dermatological, and gastrointestinal treatments. Additionally, Lavipharm SA offers cosmetic products under the brand names Castalia Soins Dermocosmetiques and Laviderm Active Technology, targeting skin, face, body, scalp, and hair care. The company also distributes over-the-counter (OTC) products such as cold and flu remedies, oral care items, dermatological products, condoms, antiseptics, analgesics, laxatives, and gynecological products. Lavipharm SA is the parent company of the Lavipharm Group of Companies. In January 2014, Robertet SA, alongside CODIF, acquired HITEX, a company specializing in carbon dioxide extraction subcontracting, from Lavipharm SA. The company maintains a website at https://www.lavipharm.com/. Lavipharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lavipharm stock

Total Assets per Share of Lavipharm is 0.77 EUR in 2025.

Total Assets per Share of Lavipharm changed from 0.74 EUR to 0.77 EUR, representing a 3.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Lavipharm since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Lavipharm

All Key Metrics — Lavipharm